No insider purchase over the last 90 days. The latest was filed 20 May 2026.
VNV Global AB (publ) is a Banks company. Its directors and officers file their transactions with Finansinspektionen. 4 insiders have disclosed 6 filings since 18 October 2025.
The flow runs one way only: 1 insider bought (3 purchases totalling €31.6M) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €31.3M, bought by Lars-Åke Norling and made public on 20 May 2026 (15.5% of market cap). On the buying side, the filings list 1 board member among the declarants.
For context, the typical company on the same exchange (median of 885 companies) published 7 filings over the same period, against 6 filings here. Since 2021, the database holds 5 purchases and no sales by insiders of the company.
The last purchase on record was published on 20 May 2026, which is 150 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade.
For comparison within the same sector, see the insider buying recorded at Redwood Trust Inc and First Guaranty Bancshares, Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Analysts rate VNV Global AB (publ) Strong Buy (bullish), based on 2 analysts. Average price target: SEK 26.50.
FY ended December 2025 · cache
12 of 12 declarations
VNV Global AB (publ) is an investment company focused on the healthcare technology sector. It is listed on the Stockholm Stock Exchange under the symbol XSTO.
Purchases our model currently ranks for the recommendations list.
All recommendations